TMEFF2 and breast carcinoma: In this study, we examined mRNA expression and methylation status of DRM/Gremlin in lung cancer, breast cancer, and malignant mesothelioma (MM) cell lines, as well as the methylation status of DRM/Gremlin, HPP1, and RUNX3 in several primary malignant tumours.